Evolution of the Average Target: Vaxcyte, Inc.

Evolution of the Target Price: Vaxcyte, Inc.

Changes in Analyst Recommendations: Vaxcyte, Inc.

4be57f29d974db7b433e.s46LOoy4x_FEUI_eL5hVcnqv__ZklllUoIb0qyOJUbY.h7nsCvT6kZMTKOKQQMwAPTvwtbkSrz8Q08eW6Ha5KYfK6uBz1simtQca4A~889ff8a204c0d2a2e94b56562ebe7aa1

Add to a list
Consensus 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+75.47%
+9.86%
+40%
+1.37%
+24.59%
+26.91%
+15.12%
+14.34%
+68.77%
+64.62%
Average +34.10%
Weighted average by Cap. +24.10%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
85.42USD
Average target price
149.89USD
Spread / Average Target
+75.47%
High Price Target
163.00USD
Spread / Highest target
+90.82%
Low Price Target
135.00USD
Spread / Lowest Target
+58.04%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Mizuho Securities
Needham & Co.
TD Cowen
BofA Securities
Guggenheim
SVB Securities LLC
BTIG

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. PCVX Stock
  4. Consensus Vaxcyte, Inc.